# Top 50 Medical Device Startup Investors in Asia in October 2023

## Sequoia Capital China
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 10
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Artificial Intelligence

We help founders build enduring companies.

## Qiming Venture Partners
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 10
- Stages: Series B, Series A, Series C
- Focus: Health Care, Medical, Biotechnology

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have investedin outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status.

## Cowin Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 9
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Health Care, Software

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.

## CD Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 9
- Stages: Series A, Series B, Angel
- Focus: Health Care, Biotechnology, Medical Device

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

## Lilly Asia Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 8
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto. 

## Haibang Capital
- Type: VC Fund
- Location: Hangzhou, Zhejiang, China
- Relevant deals: 8
- Stages: Series A, Angel, Series B
- Focus: Health Care, Biotechnology, Medical

Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

## BioTrack Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 7
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Medical

BioTrack Capital is a China-based investment firm.

## Addor Capital
- Type: VC Fund
- Location: Nanjing, Jiangsu, China
- Relevant deals: 6
- Stages: Series A, Series B
- Focus: Manufacturing, Medical, Electronics

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

## Legend Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 6
- Stages: Series B, Series A, Series C
- Focus: Health Care, Biotechnology, Medical

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

## Marathon Venture Partners
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 5
- Stages: Series A, Series B, Angel
- Focus: Health Care, Medical, Biotechnology

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

## SZHTI Group
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 5
- Stages: Series A, Angel
- Focus: Manufacturing, Electronics, Health Care

SZHTI Group is a company that provides asset management and financing services.

## BioVenture
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 5
- Stages: Series A, Series B, Series C
- Focus: Health Care, Medical, Biotechnology

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

## Nippon Venture Capital
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 5
- Stages: Series A, Seed
- Focus: Software, Health Care, Information Technology

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

## Share Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 4
- Stages: Series A, Series B, Angel
- Focus: Medical, Health Care, Biotechnology

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

## Taiyu Investment
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 4
- Stages: Series A, Seed, Angel
- Focus: Medical, Health Care, Biotechnology

Taiyu Investment is an investment firm.

## IDG Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 4
- Stages: Series A, Series B, Series C
- Focus: Software, Internet, E-Commerce

IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.

## Nissay Capital
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Health Care, Internet, Medical

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

## UTokyo Innovation Platform
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 4
- Stages: Series A, Seed
- Focus: Biotechnology, Medical, Health Care

The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures.

## Sunland Fund
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 4
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Biotechnology

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

## Mitsubishi UFJ Capital
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 4
- Stages: Series B, Series A
- Focus: Software, Health Care, Information Technology

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

## SND Ventures Group
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 4
- Stages: Series A, Series B, Angel
- Focus: Manufacturing, Medical, Health Care

SND Ventures Group is a venture capital and private equity firm specializing in seed investments.

## Med-Fine Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 4
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Medical

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

## Dalton Venture
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 4
- Stages: Series A, Series B, Angel
- Focus: Health Care, Medical, Medical Device

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

## Prox Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Medical, Biotechnology, Health Care

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

## CASH Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Manufacturing

CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.

## Source Code Capital
- Type: VC Fund
- Location: Chaoyang, Liaoning, China
- Relevant deals: 3
- Stages: Series B, Series A, Series C
- Focus: Software, E-Commerce, Artificial Intelligence

Founded in 2014, Source Code Capital is a leading China VC focused on the broad TMT sectors and investing in both early stage start-ups and growth stage companies. With $1.5 billion and RMB 3.5 billion under management, Source Code Capital has been successfully partnering with close to 150 leading Chinese technology founders since inceptionincluding Bytedance, Meituan, Homelink, among many others. Source Code is focused on the “Big 3” fundamental drivers, which are Internet+, AI+, and Global+ , and invests along sectors such as media and entertainment, consumer services, enterprise, finance, retail, transportation, housing, education, and healthcare.

## Fortune Venture Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Information Technology, Health Care

Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.

## Redhill Capital
- Type: VC Fund
- Location: Guangzhou, Guangdong, China
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Health Care, Medical, Medical Device

Redhill Capital is a venture capital firm specializing in early stage investment. It primary invests in medical industry.

## Oriza Seed Capital (Oriza Yuandian)
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 3
- Stages: Series A, Angel, Seed
- Focus: Health Care, Manufacturing, Biotechnology

Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.

## SBI Investment
- Type: VC Fund
- Location: Minato, Chiba, Japan
- Relevant deals: 3
- Stages: Series B, Series A
- Focus: Financial Services, Information Technology, Software

SBI Investment supports the business development and growth of private venture companies through fund investment.

## Volcanics Venture
- Type: VC Fund
- Location: Changning, Shanghai, China
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Software

Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.

## Long Hill Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 3
- Stages: Series A, Series B, Angel
- Focus: Medical, Health Care, Training

Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.

## Oriental Fortune Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Software, Information Technology, E-Commerce

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

## Shunwei Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Internet, E-Commerce, Software

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.Shunwei Capital is a China-based company that was founded in 2011 by Tuck Lye Koh and Lei Jun.

## CMB International Capital Corporation
- Type: VC Fund
- Location: Central, Hong Kong Island, Hong Kong
- Relevant deals: 3
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Manufacturing

CMB International Capital Corporation is an investment banking firm that offers comprehensive professional services and financial advisory services. It provides mergers and acquisitions, initial public offering, equity underwriting, company restructuring, project financing, and business consulting services. CMB International Capital Corporationprovides corporate finance, asset management, wealth management and securities brokerage services. Additionally, it offers debt financing and transaction advisory services, placement of shares and refinancing for listed companies. CMB International Capital Corporation’s clientele include institutional, corporate and individual customers both domestic and overseas. It began operation in 1987, with its headquarters in Central in Hong Kong as a subsidiary of China Merchants Bank.

## Highlight Capital
- Type: VC Fund
- Location: Nanjin, Jiangsu, China
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Medical

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

## Cenova
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 3
- Stages: Series B, Series A, Series C
- Focus: Health Care, Medical, Pharmaceutical

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

## Huagai Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 3
- Stages: Series A, Series B, Angel
- Focus: Health Care, Biotechnology, Medical

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

## Prosperico Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Medical, Health Care, Biotechnology

Prosperico Ventures is a venture capital firm focused on healthcare and the high-tech industry.

## Keio Innovation Initiative
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Medical, Health Care, Biotechnology

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

## EFung Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

## Shenzhen Capital Group
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Health Care, Software

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation and emerging industriesdeveloping. SCGC has registered capital of 5.42 billion RMB, andtotal AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based of the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

## Jinding Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Manufacturing, Health Care, E-Commerce

Jinding Capital is a leading industrial equity investment institution in China.

## Oriza Holdings
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Manufacturing

Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.

## Legend Star
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 2
- Stages: Series A, Angel, Seed
- Focus: Health Care, Medical, Biotechnology

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

## 6 Dimensions Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Medical

6 Dimensions Capital was established in May, 2017 through the merger of Frontline BioVentures and WuXi Healthcare Ventures.
The two prominent and experienced teams formed a healthcare focused investment firm with an in-depth focus and extensive coverage both in China and global market.

## CCB International
- Type: VC Fund
- Location: Central, Hong Kong Island, Hong Kong
- Relevant deals: 2
- Stages: Series C, Series A, Series B
- Focus: Health Care, Biotechnology, Medical

CCB International (Holdings) Limited and its subsidiaries (CCB International) is an investment services flagship which is owned by China Construction Bank Corporation ("CCB"). Its core business is divided into three main areas, namely Pre-IPO, IPO and Post-IPO which in turn form a comprehensive investment services value chain that offersa full range of products, and services including sponsoring and underwriting, financial advisory, corporate mergers and acquisitions and restructuring, additional issuance and placement of shares and refinancing forlisted companies, direct investment, asset management, securities brokerage, market research, investment consultancy, etc.

## Grand Mount Capital
- Type: VC Fund
- Relevant deals: 2
- Stages: Series B, Series A, Angel
- Focus: Biotechnology, Medical, Health Care

Grand Mountain Capital or to discuss a specific investment opportunity.

## Dingxin Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Medical, Health Care, Biotechnology

Dingxin Capital is an investment management agency that specializes in equity investments. The partners are mainly from domestic first-line investment institutions such as CDH, Jiuding and Zhongjin. They have deep accumulation and rich experience in the equity investment field, paying attention to the construction of the whole organization andtrying to build a truly sustainable competition. Investment institutions.

## iSGS Investment Works
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: E-Commerce, Software, Information Technology

iSGS Investment Works is Japan-based venture capital firm.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co